1. |
|
2. |
Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 1994, 149(3 Pt 1): 818-24.
|
3. |
|
4. |
|
5. |
|
6. |
Dong G, Wang F, Xu L, et al. Serum interleukin-18: A novel prognostic indicator for acute respiratory distress syndrome. Medicine (Baltimore). 2019, 98(21): e15529.
|
7. |
|
8. |
|
9. |
|
10. |
|
11. |
Pliyev BK, Menshikov MY. Release of the soluble urokinase-type plasminogen activator receptor (suPAR) by activated neutrophils in rheumatoid arthritis. Inflammation. 2010, 33(1): 1-9.
|
12. |
|
13. |
|
14. |
|
15. |
|
16. |
葛均波, 徐永健, 王辰. 内科学. 北京: 人民卫生出版社, 2018: 130-131.
|
17. |
|
18. |
|
19. |
|
20. |
|
21. |
|
22. |
|
23. |
|
24. |
|
25. |
|
26. |
|
27. |
|
28. |
|
29. |
|
30. |
|
31. |
Li F, Yin R, Guo Q. Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies. Ther Adv Respir Dis, 2020, 14: 1753466620905274.
|
32. |
|
33. |
|
34. |
|
35. |
Chen J, Lv X, He H, et al. Significance of vascular endothelium growth factor testing in exhaled breath condensate of patients with acute respiratory distress syndrome. Technol Health Care. 2020;28(S1): 347-354.
|
36. |
|
37. |
|
38. |
|
39. |
|
40. |
|
41. |
|
42. |
|
43. |
|
44. |
|
45. |
Pehlivanlar-Kucuk M, Kucuk AO, Ozturk CE, et al. The Association Between Serum Uric Acid Level and Prognosis in Critically Ill Patients, Uric Acid as a Prognosis Predictor. Clin Lab. 2018, 64(9): 1491-1500.
|
46. |
|
47. |
Luporini RL, Pott-Junior H, Di Medeiros Leal MCB, et al. Phenylalanine and COVID-19: Tracking disease severity markers. Int Immunopharmacol, 2021, 101(Pt A): 108313.
|
48. |
|
49. |
|
50. |
Tanaka T, Mori M, Tashiro M, et al. Impact of Plasma 5 Hydroxyindoleacetic Acid, a Serotonin Metabolite, on Clinical Severity in Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021, 16;8: 785409.
|
51. |
|
52. |
|
53. |
|
54. |
|
55. |
|
56. |
|
57. |
Ranjeva S, Pinciroli R, Hodell E, et al. Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019. EClinicalMedicine. 2021, 34: 100829.
|
58. |
|
59. |
|
60. |
|
61. |
|
62. |
|
63. |
|
64. |
|
65. |
|